Search Results - "Kafi, Hamidreza" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Efficacy and safety of a proposed omalizumab biosimilar compared to the reference product in the management of uncontrolled moderate-to-severe allergic asthma: a multicenter, phase III, randomized, double-blind, equivalency clinical trial

Efficacy and safety of a proposed omalizumab biosimilar compared to the reference product in the management of uncontrolled moderate-to-severe allergic asthma: a multicenter, phase III, randomized, double-blind, equivalency clinical trial

by Ghanei, Mostafa, Ghalebaghi, Babak, Sami, Ramin, Torabizadeh, Mehdi, Mirsadraee, Majid, Amra, Babak, Tavakol, Marzieh, Raji, Hanieh, Fallahpour, Morteza, Kiani, Arda, Abedini, Atefeh, Jabbari Azad, Farahzad, Mahdaviani, Seyed Alireza, Attaran, Davood, Samet, Mohammad, Tavana, Sasan, Haddadzadeh shoushtari, Maryam, Nazari, Javad, AghaeiMeybodi, FatemehAlsadat, Fazlollahi, Mohammad Reza, Ghasemi, Ramin, Sabzvari, Araz, Kafi, Hamidreza, Idani, Esmaeil
Published in Frontiers in immunology (29.07.2024)

Get full text

Journal Article

Safety and Discontinuation Rate of Dimethyl Fumarate (Zadiva ® ) in Patients with Multiple Sclerosis: An Observational Retrospective Study

Safety and Discontinuation Rate of Dimethyl Fumarate (Zadiva ® ) in Patients with Multiple Sclerosis: An Observational Retrospective Study

by Abolfazli, Roya, Sahraian, Mohammad Ali, Tayebi, Atefeh, Kafi, Hamidreza, Samadzadeh, Sara
Published in Journal of clinical medicine (27.07.2023)

Get full text

Journal Article

Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial

Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial

by Allahyari, Abolghasem, Ehsanpour, Ali, Najafi, Behrouz, Ansarinejad, Nafiseh, Mehrzad, Valiollah, Kalantari, Behjat, Raafat, Jahangir, Ghadiany, Mojtaba, Shahi, Farhad, Gharib, Behrooz, Moazed, Vahid, Khosravi, Adnan, Mirpour, Mir Hossein, Salari, Sina, Mortazavizadeh, Seyedmohammadreza, Nekoyi, Amirabbas, Khani, Mohsen, Sadeghi, Alireza, Gharib, Sirus, Bary, Alireza, Mirzania, Mehrzad, Haghighat, Shirin, Razavi, Seyed Mohsen, Emami, Seyed Amir Hossein, Hosseinzadeh, Mehran, Mirbolouk, Mahdi, Sadighi, Sanambar, Shahrasbi, Abdolali, Esfahani, Ali, Gity, Masoumeh, Anjidani, Nassim, Kafi, Hamidreza, Najafi, Safa
Published in BMC cancer (07.09.2022)

Get full text

Journal Article

Alvopem ® (pemetrexed) safety assessment in patients with non-small cell lung cancer or malignant pleural mesothelioma: a post-marketing surveillance

Alvopem ® (pemetrexed) safety assessment in patients with non-small cell lung cancer or malignant pleural mesothelioma: a post-marketing surveillance

by Seifi, Sharareh, Salimi, Babak, Monfared, Zahra Esfahani, Sabahi, Cyrus, Kafi, Hamidreza, Khosravi, Adnan
Published in Journal of pharmaceutical policy and practice (25.01.2023)

Get full text

Journal Article

A randomized, double-blind, phase III, non-inferiority clinical trial comparing the efficacy and safety of TA4415V (a proposed Trastuzumab biosimilar) and Herceptin (Trastuzumab reference product) in HER2-positive early-stage breast Cancer patients

A randomized, double-blind, phase III, non-inferiority clinical trial comparing the efficacy and safety of TA4415V (a proposed Trastuzumab biosimilar) and Herceptin (Trastuzumab reference product) in HER2-positive early-stage breast Cancer patients

by Nodehi, Reza Safaei, Kalantari, Behjat, Raafat, Jahangir, Ansarinejad, Nafiseh, Moazed, Vahid, Mortazavizadeh, Seyed Mohammad Reza, Hosseinzadeh, Mehran, Ghaderi, Bayazid, Jenabian, Arash, Qadyani, Mojtaba, Haghighat, Shirin, Allahyari, Abolghasem, Mirzania, Mehrzad, Seghatoleslami, Mohammad, Payandeh, Mehrdad, Alikhasi, Afsaneh, Kafi, Hamidreza, Shahi, Farhad
Published in BMC pharmacology & toxicology (28.07.2022)

Get full text

Journal Article

Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2–adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-controlled trial

Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2–adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-controlled trial

by Tabarsi, Payam, Anjidani, Nassim, Shahpari, Ramin, Mardani, Masoud, Sabzvari, Araz, Yazdani, Babak, Kafi, Hamidreza, Fallah, Newsha, Ebrahimi, Ali, Taheri, Ali, Petrovsky, Nikolai, Barati, Saghar
Published in Clinical microbiology and infection (01.02.2023)

Get full text

Journal Article

Ability of SpikoGen®, an Advax‐CpG adjuvanted recombinant spike protein vaccine, to induce cross‐neutralising antibodies against SARS‐CoV‐2 variants

Ability of SpikoGen®, an Advax‐CpG adjuvanted recombinant spike protein vaccine, to induce cross‐neutralising antibodies against SARS‐CoV‐2 variants

by Honda‐Okubo, Yoshikazu, Antipov, Anna, Andre, Greiciely, Barati, Saghar, Kafi, Hamidreza, Petrovsky, Nikolai
Published in Immunology (01.10.2023)

Get full text

Journal Article

Immunogenicity and Safety of SpikoGen, an Adjuvanted Recombinant SARS-CoV-2 Spike Protein, as a Heterologous Third Booster Dose in Kidney Transplant Patients: A Single-arm Clinical Trial

Immunogenicity and Safety of SpikoGen, an Adjuvanted Recombinant SARS-CoV-2 Spike Protein, as a Heterologous Third Booster Dose in Kidney Transplant Patients: A Single-arm Clinical Trial

by Nafar, Mohsen, Mostafaloo, Narges, Firouzan, Ahmad, Poorrezagholi, Fatemeh, Samadian, Fariba, Dalili, Nooshin, Barati, Saghar, Anjidani, Nassim, Kafi, Hamidreza, Shahpari, Ramin, Bayat, Mahdiye, Kianipour, Soha, Samavat, Shiva
Published in Clinical therapeutics (01.12.2022)

Get full text

Journal Article

Evaluating the Efficacy and Safety of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 Spike Protein Vaccine: A Phase 3 Randomized Placebo-Controlled Trial

Evaluating the Efficacy and Safety of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 Spike Protein Vaccine: A Phase 3 Randomized Placebo-Controlled Trial

by Tabarsi, Payam, Anjidani, Nassim, Shahpari, Ramin, Mardani, Masoud, Sabzvari, Araz, Yazdani, Babak, Kafi, Hamidreza, Fallah, Newsha, Ebrahimi, Ali, Taheri, Ali, Petrovsky, Nikolai, Barati, Saghar
Published in Clinical microbiology and infection (10.09.2022)

Get full text

Journal Article

The effects of memantine on the serum concentrations of matrix metalloproteinases and neurologic function of patients with ischemic stroke

The effects of memantine on the serum concentrations of matrix metalloproteinases and neurologic function of patients with ischemic stroke

by Beladi Moghadam, Nahid, Pourheidar, Elham, Ahmadpour, Forouzan, Kafi, Hamidreza, Salamzadeh, Jamshid, Nasiri, Saeed, Sistanizad, Mohammad
Published in Journal of clinical neuroscience (01.08.2021)

Get full text

Journal Article

Assessing the gene expression of the adenosine 5′-monophosphate-activated protein kinase (AMPK) and its relation with the IL-6 and IL-10 plasma levels in COVID-19 patients

Assessing the gene expression of the adenosine 5′-monophosphate-activated protein kinase (AMPK) and its relation with the IL-6 and IL-10 plasma levels in COVID-19 patients

by Assar, Shirin, Dastbaz, Mohammad, Amini, Komail, Roghani, Seyed Askar, Lotfi, Ramin, Taghadosi, Mahdi, Kafi, Hamidreza, Abdan, Zahra, Allahyari, Hosna, Rostampour, Rezvan, Shahrokhvand, Seyedeh Zahra
Published in Molecular biology reports (01.12.2023)

Get full text

Journal Article

Evaluating the safety and effectiveness of PegaGen® (pegfilgrastim) for the prevention of chemotherapy-induced febrile neutropenia: a post-marketing surveillance study

Evaluating the safety and effectiveness of PegaGen® (pegfilgrastim) for the prevention of chemotherapy-induced febrile neutropenia: a post-marketing surveillance study

by Jenabian, Arash, Ehsanpour, Ali, Mortazavizadeh, Seyed Mohammad Reza, Raafat, Jahangir, Razavi, Mohsen, Khosravi, Adnan, Seifi, Sharareh, Salimi, Babak, Anjidani, Nassim, Kafi, Hamidreza
Published in Supportive care in cancer (01.10.2022)

Get full text

Journal Article

Efficacy and safety of peginterferon beta-1a compared to interferon beta-1a in relapsing remitting multiple sclerosis patients: A phase 3, randomized, non-inferiority clinical trial (PEGINTEGRITY)

Efficacy and safety of peginterferon beta-1a compared to interferon beta-1a in relapsing remitting multiple sclerosis patients: A phase 3, randomized, non-inferiority clinical trial (PEGINTEGRITY)

by Shaygannejad, Vahid, Ashtari, Fereshteh, Saeidi, Morteza, Beladi Moghadam, Nahid, Ghalyanchi Langroodi, Hamidreza, Baghbanian, Seyed Mohammad, Abolfazli, Roya, Ghiasian, Masoud, Ayromlou, Hormoz, Asadollahzadeh, Elnaz, Sabzvari, Araz, Kafi, Hamidreza, Azimi Saeen, Amirreza
Published in Multiple sclerosis and related disorders (01.10.2024)

Get full text

Journal Article

Efficacy and Safety of a Biosimilar Liraglutide (Melitide®) Versus the Reference Liraglutide (Victoza®) in People with Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Noninferiority Clinical Trial

Efficacy and Safety of a Biosimilar Liraglutide (Melitide®) Versus the Reference Liraglutide (Victoza®) in People with Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Noninferiority Clinical Trial

by Esteghamati, Alireza, Zamanzadeh, Mehran, Malek, Mojtaba, Khaledi, Mohammad, Monavari, Arezoo, Najafi, Laily, Banazadeh, Zahra, Malboosbaf, Ramin, Aghili, Rokhsareh, Mahdikhah, Sedigheh, Ganjizadeh-Zavereh, Hasan, Kafi, Hamidreza, Hosseinpanah, Farhad, Khamseh, Mohammad Ebrahim
Published in Diabetes therapy (01.11.2023)

Get full text

Journal Article

Study of the neuroprotective effects of memantine in patients with mild to moderate ischemic stroke

Study of the neuroprotective effects of memantine in patients with mild to moderate ischemic stroke

by Kafi, Hamidreza, Salamzadeh, Jamshid, Beladimoghadam, Nahid, Sistanizad, Mohammad, Kouchek, Mehran
Published in Iranian journal of pharmaceutical research : IJPR (2014)

Get full text

Journal Article

Evaluating the Efficacy and Safety of Aflibercept Biosimilar (P041) Compared with Originator Product in Patients with Neovascular Age-Related Macular Degeneration

Evaluating the Efficacy and Safety of Aflibercept Biosimilar (P041) Compared with Originator Product in Patients with Neovascular Age-Related Macular Degeneration

by Karkhaneh, Reza, Faghihi, Hooshang, Riazi-Esfahani, Hamid, Abrishami, Mojtaba, Bazvand, Fatemeh, Ebrahimiadib, Nazanin, Johari, Mohammadkarim, Akhlaghi, Mohammadreza, Shoeibi, Nasser, Norouzzadeh, Mohammad Hossein, Ansari Astaneh, Mohammad Reza, Khojasteh, Hassan, Imani Fooladi, Marjan, Khodabande, Alireza, Ghassemi, Fariba, Khalili Pour, Elias, Zarei, Mohammad, Mirshahi, Ahmad, Fazel, Farhad, Ashraf, Hossein, Hosseini, Seyedeh Maryam, Dourandeesh, Maryam, Feghhi, Mostafa, Alizadeh, Yousef, Behboudi, Hassan, Azadi, Pejvak, Sabzvari, Araz, Kafi, Hamidreza, Ghasemi Falavarjani, Khalil
Published in Ophthalmology retina (01.08.2024)

Get more information

Journal Article

Increasing the number of adverse drug reactions reporting: the role of clinical pharmacy residents

Increasing the number of adverse drug reactions reporting: the role of clinical pharmacy residents

by Baniasadi, Shadi, Habibi, Maryam, Haghgoo, Roodabeh, Karimi Gamishan, Masoumeh, Dabaghzadeh, Fatemeh, Farasatinasab, Maryam, Farsaei, Shadi, Gharekhani, Afshin, Kafi, Hamidreza, Karimzadeh, Iman, Kharazmkia, Ali, Najmeddin, Farhad, Nikvarz, Naemeh, Oghazian, Mohammad Bagher, Rezaee, Haleh, Sadeghi, Kourosh, Tafazzoli, Ali, Shahsavari, Nahid, Fahimi, Fanak
Published in Iranian journal of pharmaceutical research : IJPR (2014)

Get full text

Journal Article